Anna-Maria Hoffmann-Vold, M.D., Ph.D., discusses the most common symptoms of progressive pulmonary fibrosis (PPF), how they typically evolve and the impact of PPF on patients’ daily activities and quality of life as the disease progresses.
Video content above is prompted by the following:
Value-Based Decision-Making in Metastatic Breast Cancer
September 16th 2021In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.
Read More